These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 3093415
21. Enhancement of fractionated radiation therapy by an experimental concentrated perflubron emulsion (Oxygent) in the Lewis lung carcinoma. Teicher BA, Herman TS, Menon K. Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):899-902. PubMed ID: 1391530 [Abstract] [Full Text] [Related]
22. Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA/carbogen/radiation. Holden SA, Herman TS, Teicher BA. Radiother Oncol; 1990 May; 18(1):59-70. PubMed ID: 2113698 [Abstract] [Full Text] [Related]
23. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo. Kim GE, Song CW. Cancer Chemother Pharmacol; 1989 May; 25(2):99-102. PubMed ID: 2513138 [Abstract] [Full Text] [Related]
24. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity. Teicher BA, Bernal SD, Holden SA, Cathcart KN. Cancer Chemother Pharmacol; 1988 May; 21(4):281-5. PubMed ID: 3131032 [Abstract] [Full Text] [Related]
25. Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma. Teicher BA, Holden SA, Rose CM. Int J Cancer; 1986 Aug 15; 38(2):285-8. PubMed ID: 3089945 [Abstract] [Full Text] [Related]
26. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice. Fingar VH, Mang TS, Henderson BW. Cancer Res; 1988 Jun 15; 48(12):3350-4. PubMed ID: 3130983 [Abstract] [Full Text] [Related]
27. Effects of Fluosol-DA and oxygen breathing on adriamycin antitumor activity and cardiac toxicity in mice. Teicher BA, Holden SA, Crawford JM. Cancer; 1988 Jun 01; 61(11):2196-201. PubMed ID: 3365649 [Abstract] [Full Text] [Related]
28. Use of perfluorochemical emulsions in cancer therapy. Teicher BA. Biomater Artif Cells Immobilization Biotechnol; 1992 Jun 01; 20(2-4):875-82. PubMed ID: 1391527 [Abstract] [Full Text] [Related]
30. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen. Song CW, Lee I, Hasegawa T, Rhee JG, Levitt SH. Cancer Res; 1987 Jan 15; 47(2):442-6. PubMed ID: 3098409 [Abstract] [Full Text] [Related]
31. Oxygen-carrying perfluorochemical emulsion as an adjuvant to radiation therapy in mice. Teicher BA, Rose CM. Cancer Res; 1984 Oct 15; 44(10):4285-8. PubMed ID: 6467189 [Abstract] [Full Text] [Related]
37. Optimization of perfluorochemical levels with radiation therapy in mice. Teicher BA, Herman TS, Jones SM. Cancer Res; 1989 May 15; 49(10):2693-7. PubMed ID: 2713854 [Abstract] [Full Text] [Related]
38. A clinical trial of Fluosol DA 20% in advanced squamous cell carcinoma of the head and neck. Rose C, Lustig R, McIntosh N, Teicher B. Int J Radiat Oncol Biol Phys; 1986 Aug 15; 12(8):1325-7. PubMed ID: 3759553 [Abstract] [Full Text] [Related]
39. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo. Chaplin DJ, Horsman MR, Aoki DS. Br J Cancer; 1991 Jan 15; 63(1):109-13. PubMed ID: 1846549 [Abstract] [Full Text] [Related]
40. Increase in tumor pO2 by perfluorochemicals and carbogen. Hasegawa T, Rhee JG, Levitt SH, Song CW. Int J Radiat Oncol Biol Phys; 1987 Apr 15; 13(4):569-74. PubMed ID: 3104250 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]